01 1AbbVie Inc.
02 1Biophore India Pharmaceuticals Pvt. Ltd
03 1Dr. Reddy's Laboratories Limited
04 1Neuland Laboratories Limited
05 1Formosa Laboratories, Inc.
06 1Glenmark Life Sciences Limited
07 2HETERO LABS LIMITED
08 1MSN Life Sciences Private Limited
09 1ScinoPharm Taiwan Ltd.
10 1Shanghai Desano Chemical Pharmaceutical Co., Ltd.
11 1TAPI Croatia Industries Ltd.
01 1ELAGOLIX SODIUM
02 8Elagolix Sodium
03 3Elagolix sodium
01 1China
02 7India
03 2Taiwan
04 1U.S.A
05 1Blank
NDC Package Code : 0051-0040
Start Marketing Date : 2020-11-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
NDC Package Code : 73435-021
Start Marketing Date : 2021-12-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-025
Start Marketing Date : 2020-12-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58032-1028
Start Marketing Date : 2022-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66499-0072
Start Marketing Date : 2020-08-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-958
Start Marketing Date : 2021-09-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0131
Start Marketing Date : 2018-07-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-1443
Start Marketing Date : 2020-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42931-320
Start Marketing Date : 2022-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11722-074
Start Marketing Date : 2021-03-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Elagolix Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elagolix Sodium, including repackagers and relabelers. The FDA regulates Elagolix Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elagolix Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Elagolix Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Elagolix Sodium supplier is an individual or a company that provides Elagolix Sodium active pharmaceutical ingredient (API) or Elagolix Sodium finished formulations upon request. The Elagolix Sodium suppliers may include Elagolix Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Elagolix Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Elagolix Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Elagolix Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Elagolix Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Elagolix Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Elagolix Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Elagolix Sodium suppliers with NDC on PharmaCompass.
We have 10 companies offering Elagolix Sodium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?